Indaptus Therapeutics Correlations

INDP Stock  USD 2.30  0.01  0.43%   
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Good diversification

The correlation between Indaptus Therapeutics and NYA is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and NYA in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.

Moving together with Indaptus Stock

  0.7XFOR X4 PharmaceuticalsPairCorr

Moving against Indaptus Stock

  0.64LFCR Lifecore Biomedical Financial Report 6th of June 2024 PairCorr
  0.62MREO Mereo BioPharma Group Earnings Call This WeekPairCorr
  0.61IRWD Ironwood PharmaceuticalsPairCorr
  0.56RDY Dr Reddys LaboratoriesPairCorr
  0.55INCY IncytePairCorr
  0.5JNJ Johnson Johnson Financial Report 18th of July 2024 PairCorr
  0.44LSDI Lucy Scientific DiscoveryPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
High negative correlations   

Risk-Adjusted Indicators

There is a big difference between Indaptus Stock performing well and Indaptus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Indaptus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RZLT  4.80  1.34  0.20 (16.34) 5.45 
TPST  4.10 (0.19) 0.00 (0.73) 0.00 
CMRA  8.29 (2.21) 0.00  1.30  0.00 
FBRX  2.92 (0.15) 0.00  1.16  0.00 
ABVC  3.78 (0.09) 0.00 (0.54) 0.00 
KTTA  3.00  0.05  0.01  0.13  3.29 
BTTX  9.22 (1.34) 0.00  1.92  0.00 
NTRB  5.10  1.14  0.20 (2.42) 4.46 
QNRX  4.01 (1.58) 0.00  0.88  0.00 
LGVN  6.17 (1.39) 0.00  0.93  0.00 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Indaptus Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now


Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Indaptus Therapeutics Corporate Management

Elected by the shareholders, the Indaptus Therapeutics' board of directors comprises two types of representatives: Indaptus Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Indaptus. The board's role is to monitor Indaptus Therapeutics' management team and ensure that shareholders' interests are well served. Indaptus Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Indaptus Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBAChief OfficerProfile
Jeffrey MecklerCEO DirectorProfile
Walt EsqChief OfficerProfile
Michael NewmanChief FounderProfile
Boyan MDChief OfficerProfile

Already Invested in Indaptus Therapeutics?

The danger of trading Indaptus Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Indaptus Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Indaptus Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Indaptus Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Indaptus Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Indaptus Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Indaptus Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Indaptus Therapeutics Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.
Note that the Indaptus Therapeutics information on this page should be used as a complementary analysis to other Indaptus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Indaptus Stock analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is Indaptus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Indaptus Therapeutics. If investors know Indaptus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Indaptus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of Indaptus Therapeutics is measured differently than its book value, which is the value of Indaptus that is recorded on the company's balance sheet. Investors also form their own opinion of Indaptus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Indaptus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Indaptus Therapeutics' market value can be influenced by many factors that don't directly affect Indaptus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Indaptus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Indaptus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Indaptus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.